A significant advance in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This essential malignant protector protein is frequently inactivated in various types of malignancies, https://iwanttobookmark.com/story22104109/nanobodies-restore-p53-new-promising-hope-for-tumor-treatment